Area of research
Molecular Biology · Oncology
Research interest
Research interests include DNA Repair Mechanisms, PARP inhibition in cancer therapy, Carcinogens and Genotoxicity Assessment, and DNA and Nucleic Acid Chemistry.
A multi-scale map of protein assemblies in the DNA damage response
SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity
A specific inhibitor of ALDH1A3 regulates retinoic acid biosynthesis in glioma stem cells
Mechanisms of MTH1 inhibition-induced DNA strand breaks: The slippery slope from the oxidized nucleotide pool to genotoxic damage
Next generation high throughput DNA damage detection platform for genotoxic compound screening
Next generation high throughput DNA damage detection platform for genotoxic compound screening
DSpace@MIT (Massachusetts Institute of Technology) 2018cited by 0position: last
Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease
Oxidative guanine base damage regulates human telomerase activity
A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy
Abstract NG02: A network of deeply conserved synthetic-lethal interactions for exploration of precision cancer therapy
Abstract 129: RAD17 loss of function is synthetically lethal with the checkpoint kinase inhibitors AZD7762 or MK-1775
Mitochondria, Energetics, Epigenetics, and Cellular Responses to Stress
ATM Regulates 3-Methylpurine-DNA Glycosylase and Promotes Therapeutic Resistance to Alkylating Agents
Mutation research/fundamental and molecular mechanisms of mutagenesis
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
MELK-Dependent FOXM1 Phosphorylation is Essential for Proliferation of Glioma Stem Cells